Are you sure?

GVH fines Abbott Laboratories for misleading consumers

The Competition Office (GVH) announced on Thursday it fined drugmaker Abbott Laboratories Hungary Kft Ft 8 million for misleading consumers.

GVH said Abbott Laboratories had, during periods in 2004 and 2005, placed brochures with doctors which made unsubstantiated comparisons between the active ingredient of one of its own drugs and the active ingredient in another drug made by a competitor. GVH noted that such comparisons must first be approved by the National Pharmaceutical Institute.